This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through November 3, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-growth: Archive
Here is Why Growth Investors Should Buy Agnico (AEM) Now
by Zacks Equity Research
Agnico (AEM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
AEMNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why Growth Investors Shouldn't Overlook Subsea 7 (SUBCY)
by Zacks Equity Research
Subsea 7 (SUBCY) possesses solid growth attributes, which could help it handily outperform the market.
SUBCYNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why Growth Investors Shouldn't Overlook Allient (ALNT)
by Zacks Equity Research
Allient (ALNT) could produce exceptional returns because of its solid growth attributes.
ALNTNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
Wall Street Bulls Look Optimistic About ATI (ATI): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), ATI (ATI) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ATINegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Superior Group (SGC) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Superior Group (SGC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SGCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Agnico (AEM) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Agnico (AEM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
AEMNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Monday.com (MNDY) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Monday.com (MNDY) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
MNDYNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Hamilton Insurance (HG): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Hamilton Insurance (HG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
HGPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Unity Software (U) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Unity Software (U) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
UNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Celsius (CELH): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Celsius (CELH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CELHNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Ouster (OUST) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Ouster (OUST) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
OUSTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Blue Bird (BLBD): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Blue Bird (BLBD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BLBDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Kyndryl Holdings, Inc. (KD) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Kyndryl Holdings, Inc. (KD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
KDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
3 Reasons Growth Investors Will Love New Gold (NGD)
by Zacks Equity Research
New Gold (NGD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
NGDNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Growth Investors Will Love Equinox Gold (EQX)
by Zacks Equity Research
Equinox Gold (EQX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
EQXPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Brokers Suggest Investing in Marvell (MRVL): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Marvell (MRVL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
MRVLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Vital Farms (VITL) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Vital Farms (VITL). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
VITLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in AudioEye (AEYE) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in AudioEye (AEYE). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
AEYENegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Carnival (CCL): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Carnival (CCL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CCLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Alaska Air (ALK) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Alaska Air (ALK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ALKNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Dutch Bros (BROS) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Dutch Bros (BROS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BROSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Look Bullish on New Gold (NGD): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), New Gold (NGD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
NGDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Ross Stores (ROST) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Ross Stores (ROST) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ROSTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Howmet (HWM) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Howmet (HWM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
HWMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Emcor Group (EME): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Emcor Group (EME) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
EMENegative Net Change
broker-rating earnings-estimates-revisions earnings-growth